|
Today we are introducing what is clearly the world’s next major renewable energy player: ecoTECH Energy Group, Inc. (OTCBB: ECTH). The Company is positioned to generate nearly $200M in revenue in the next two years with huge operating profitability. Bottom line: ECTH could rise by nearly five-fold over the next six months.
|
|
Read more...
|
Leveraging its proprietary non-invasive technology, SANUWAVE is well positioned to garner a share of multiple regenerative medicine market segments totaling $10 billion.
The Company has already completed a pivotal Phase III Investigational Device Exemption (IDE) clinical trial for the treatment of diabetic foot ulcers for its dermaPACE® device. The trial was very favorable, demonstrating statistically and clinically significant results. The dermaPACE® device to treat diabetic foot ulcers could be approved sometime in 1H12
Read more... |
Nuvilex has been transformed from a cult-stock with a quirky history to an emerging, broad-based, multi-functional, therapeutic enhancement platform. Think back to the BASF commercials from the late 1990’s. “We don’t make….we make everything better.” In essence, that is what Nuvilex has with the live-cell encapsulation technology/delivery platform being acquired as part of the SG Austria transaction.
Read more... |
|
Earlier this morning, SunSi Energies, Inc. announced solid fiscal 4Q11 and FY11 financial results that included the Company’s first-ever quarterly profit.
|
|
Read more...
|
|
Early this morning, OHR announced that it was awarded a patent that includes claims related to composition of matter for the lactate salt form of Squalamine and its delivery using any pharmaceutically acceptable carrier.
|
|
Read more...
|
|
It should be a rough ride. But here is a company that is growing revenues at an amazing clip, prompting an increase in our forecast READMORE |
|
1Q12 Results Preview; Company in Great Shape
On Thursday, August 4th, after the close, Oculus is slated to release 1Q12 results, for the period ending June 30, 2011.
While we expect results to be in line with our expectations, we believe investors should focus on the Company’s current positioning and trends, as Oculus is in great shape to achieve its objectives. Read More
|
|
|
<< Start < Prev 41 42 43 44 45 46 47 Next > End >>
|
|
Page 47 of 47 |
